A detailed history of Alliancebernstein L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 250,861 shares of RVMD stock, worth $13.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250,861
Previous 319,618 21.51%
Holding current value
$13.6 Million
Previous $12.4 Million 8.37%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.92 - $47.94 $2.54 Million - $3.3 Million
-68,757 Reduced 21.51%
250,861 $11.4 Million
Q2 2024

Aug 14, 2024

SELL
$30.14 - $40.68 $112,904 - $152,387
-3,746 Reduced 1.16%
319,618 $12.4 Million
Q1 2024

May 14, 2024

BUY
$26.56 - $33.55 $82,840 - $104,642
3,119 Added 0.97%
323,364 $10.4 Million
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $1.18 Million - $2.19 Million
64,202 Added 25.07%
320,245 $9.18 Million
Q3 2023

Nov 14, 2023

SELL
$25.17 - $35.05 $1.83 Million - $2.54 Million
-72,595 Reduced 22.09%
256,043 $7.09 Million
Q2 2023

Aug 15, 2023

SELL
$20.28 - $27.0 $969,627 - $1.29 Million
-47,812 Reduced 12.7%
328,638 $8.79 Million
Q1 2023

May 15, 2023

BUY
$20.76 - $30.09 $3.32 Million - $4.82 Million
160,050 Added 73.96%
376,450 $8.15 Million
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $669,400 - $966,616
-37,862 Reduced 14.89%
216,400 $5.15 Million
Q3 2022

Nov 15, 2022

BUY
$17.46 - $26.0 $994,608 - $1.48 Million
56,965 Added 28.87%
254,262 $5.01 Million
Q2 2022

Aug 15, 2022

SELL
$14.54 - $27.17 $412,514 - $770,840
-28,371 Reduced 12.57%
197,297 $3.85 Million
Q1 2022

May 13, 2022

BUY
$17.31 - $26.4 $2.08 Million - $3.17 Million
120,086 Added 113.74%
225,668 $5.76 Million
Q4 2021

Feb 14, 2022

BUY
$24.35 - $33.7 $474,386 - $656,543
19,482 Added 22.63%
105,582 $2.66 Million
Q3 2021

Nov 10, 2021

BUY
$23.95 - $33.41 $479,000 - $668,199
20,000 Added 30.26%
86,100 $2.37 Million
Q2 2021

Jul 30, 2021

BUY
$29.0 - $47.44 $258,100 - $422,216
8,900 Added 15.56%
66,100 $2.1 Million
Q1 2021

May 06, 2021

BUY
$37.21 - $54.43 $33,489 - $48,987
900 Added 1.6%
57,200 $2.62 Million
Q4 2020

Feb 08, 2021

BUY
$30.19 - $45.49 $12,076 - $18,196
400 Added 0.72%
56,300 $2.23 Million
Q3 2020

Nov 12, 2020

BUY
$22.61 - $34.8 $763,607 - $1.18 Million
33,773 Added 152.63%
55,900 $1.95 Million
Q2 2020

Aug 13, 2020

BUY
$19.65 - $39.34 $434,795 - $870,476
22,127 New
22,127 $699,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.76B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.